Skip to main content
Log in

Postoperative stereotactic radiosurgery for intracranial solitary fibrous tumors: systematic review and pooled quantitative analysis

  • Review
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Background

Intracranial solitary fibrous tumors (SFTs), formerly hemangiopericytomas (HPCs), are rare, aggressive dural-based mesenchymal tumors. While adjuvant radiation therapy has been suggested to improve local tumor control (LTC), especially after subtotal resection, the role of postoperative stereotactic radiosurgery (SRS) and the optimal SRS dosing strategy remain poorly defined.

Methods

PubMed, EMBASE, and Web of Science were systematically searched according to PRISMA guidelines for studies describing postoperative SRS for intracranial SFTs. The search strategy was defined in the authors’ PROSPERO protocol (CRD42023454258).

Results

15 studies were included describing 293 patients harboring 476 intracranial residual or recurrent SFTs treated with postoperative SRS. At a mean follow-up of 21–77 months, LTC rate after SRS was 46.4–93% with a mean margin SRS dose of 13.5–21.7 Gy, mean maximum dose of 27-39.6 Gy, and mean isodose at the 42.5–77% line. In pooled analysis of individual tumor outcomes, 18.7% of SFTs demonstrated a complete SRS response, 31.7% had a partial response, 18.9% remained stable (overall LTC rate of 69.3%), and 30.7% progressed. When studies were stratified by margin dose, a mean margin dose > 15 Gy showed an improvement in LTC rate (74.7% versus 65.7%).

Conclusions

SRS is a safe and effective treatment for intracranial SFTs. In the setting of measurable disease, our pooled data suggests a potential dose response of improving LTC with increasing SRS margin dose. Our improved understanding of the aggressive biology of SFTs and the tolerated adjuvant SRS parameters supports potentially earlier use of SRS in the postoperative treatment paradigm for intracranial SFTs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data Availability

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. Board WCTE (2021) World Health Organization Classification of Tumours of the Central Nervous System. International Agency for Research on Cancer, Lyon

    Google Scholar 

  2. Chmielecki J, Crago AM, Rosenberg M, O’Connor R, Walker SR, Ambrogio L, Auclair D, McKenna A, Heinrich MC, Frank DA, Meyerson M (2013) Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors. Nat Genet 45:131–132. https://doi.org/10.1038/ng.2522

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Wu Y, Zhao T, Cai Y, Zheng M, Zhang Y, Qu Y, Cai Q (2023) Clinical outcomes of solitary fibrous tumors and hemangiopericytomas and risk factors related to recurrence and survival based on the 2021 WHO classification of central nervous system tumors. J Neurosurg 1–11. https://doi.org/10.3171/2023.4.JNS23147

  4. Kinslow CJ, Bruce SS, Rae AI, Sheth SA, McKhann GM, Sisti MB, Bruce JN, Sonabend AM, Wang TJC (2018) Solitary-fibrous tumor/hemangiopericytoma of the central nervous system: a population-based study. J Neurooncol 138:173–182. https://doi.org/10.1007/s11060-018-2787-7

    Article  PubMed  Google Scholar 

  5. Rutkowski MJ, Sughrue ME, Kane AJ, Aranda D, Mills SA, Barani IJ, Parsa AT (2010) Predictors of mortality following treatment of intracranial hemangiopericytoma. J Neurosurg 113:333–339. https://doi.org/10.3171/2010.3.Jns091882

    Article  PubMed  Google Scholar 

  6. Fountas KN, Kapsalaki E, Kassam M, Feltes CH, Dimopoulos VG, Robinson JS, Smith JR (2006) Management of intracranial meningeal hemangiopericytomas: outcome and experience. Neurosurg Rev 29:145–153. https://doi.org/10.1007/s10143-005-0001-9

    Article  CAS  PubMed  Google Scholar 

  7. Melone AG, D’Elia A, Santoro F, Salvati M, Delfini R, Cantore G, Santoro A (2014) Intracranial hemangiopericytoma–our experience in 30 years: a series of 43 cases and review of the literature. World Neurosurg 81:556–562. https://doi.org/10.1016/j.wneu.2013.11.009

    Article  PubMed  Google Scholar 

  8. Jääskeläinen J, Servo A, Haltia M, Wahlström T, Valtonen S (1985) Intracranial hemangiopericytoma: radiology, Surgery, radiotherapy, and outcome in 21 patients. Surg Neurol 23:227–236. https://doi.org/10.1016/0090-3019(85)90087-4

    Article  PubMed  Google Scholar 

  9. Vuorinen V, Sallinen P, Haapasalo H, Visakorpi T, Kallio M, Jääskeläinen J (1996) Outcome of 31 intracranial haemangiopericytomas: poor predictive value of cell proliferation indices. Acta Neurochir (Wien) 138:1399–1408. https://doi.org/10.1007/bf01411118

    Article  CAS  PubMed  Google Scholar 

  10. Chacko G, Chacko AG, Rajshekhar V, Muliyil JP (2006) Intracranial hemangiopericytomas: correlation of topoisomerase IIalpha expression with biologic behavior. Surg Neurol 65:11–17. https://doi.org/10.1016/j.surneu.2005.08.013

    Article  PubMed  Google Scholar 

  11. Schiariti M, Goetz P, El-Maghraby H, Tailor J, Kitchen N (2011) Hemangiopericytoma: long-term outcome revisited. Clinical article. J Neurosurg 114:747–755. https://doi.org/10.3171/2010.6.Jns091660

    Article  PubMed  Google Scholar 

  12. Sonabend AM, Zacharia BE, Goldstein H, Bruce SS, Hershman D, Neugut AI, Bruce JN (2014) The role for adjuvant radiotherapy in the treatment of hemangiopericytoma: a Surveillance, Epidemiology, and end results analysis. J Neurosurg 120:300–308. https://doi.org/10.3171/2013.10.Jns13113

    Article  PubMed  Google Scholar 

  13. Dufour H, Métellus P, Fuentes S, Murracciole X, Régis J, Figarella-Branger D, Grisoli F (2001) Meningeal hemangiopericytoma: a retrospective study of 21 patients with special review of postoperative external radiotherapy. Neurosurgery 48:756–762 discussion 762. https://doi.org/10.1097/00006123-200104000-00011

    Article  CAS  PubMed  Google Scholar 

  14. Liu J, Wu S, Zhao K, Wang J, Shu K, Lei T (2022) Clinical features, management, and prognostic factors of Intracranial Solitary Fibrous Tumor. Front Oncol 12:915273. https://doi.org/10.3389/fonc.2022.915273

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Ghia AJ, Chang EL, Allen PK, Mahajan A, Penas-Prado M, McCutcheon IE, Brown PD (2013) Intracranial hemangiopericytoma: patterns of failure and the role of radiation therapy. Neurosurgery 73:624–630 discussion 630. https://doi.org/10.1227/neu.0000000000000064

    Article  PubMed  Google Scholar 

  16. Ghose A, Guha G, Kundu R, Tew J, Chaudhary R (2017) CNS hemangiopericytoma: a systematic review of 523 patients. Am J Clin Oncol 40:223–227. https://doi.org/10.1097/coc.0000000000000146

    Article  PubMed  Google Scholar 

  17. Galanis E, Buckner JC, Scheithauer BW, Kimmel DW, Schomberg PJ, Piepgras DG (1998) Management of recurrent meningeal hemangiopericytoma. Cancer 82:1915–1920

    Article  CAS  PubMed  Google Scholar 

  18. Kondziolka D, Flickinger JC, Lunsford LD (2008) The principles of skull base radiosurgery. Neurosurg Focus 24:E11. https://doi.org/10.3171/foc/2008/24/5/e11

    Article  PubMed  Google Scholar 

  19. Coffey RJ, Cascino TL, Shaw EG (1993) Radiosurgical treatment of recurrent hemangiopericytomas of the meninges: preliminary results. J Neurosurg 78:903–908. https://doi.org/10.3171/jns.1993.78.6.0903

    Article  CAS  PubMed  Google Scholar 

  20. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg 88:105906. https://doi.org/10.1016/j.ijsu.2021.105906

    Article  PubMed  Google Scholar 

  21. Schardt C, Adams MB, Owens T, Keitz S, Fontelo P (2007) Utilization of the PICO framework to improve searching PubMed for clinical questions. BMC Med Inform Decis Mak 7:16. https://doi.org/10.1186/1472-6947-7-16

    Article  PubMed  PubMed Central  Google Scholar 

  22. Munn Z, Barker TH, Moola S, Tufanaru C, Stern C, McArthur A, Stephenson M, Aromataris E (2020) Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evid Synth 18:2127–2133. https://doi.org/10.11124/jbisrir-d-19-00099

    Article  PubMed  Google Scholar 

  23. Wells GA SB, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P (2011) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses

  24. Chang SD, Sakamoto GT (2003) The role of radiosurgery for hemangiopericytomas. Neurosurg Focus 14:e14. https://doi.org/10.3171/foc.2003.14.5.15

    Article  PubMed  Google Scholar 

  25. Cohen-Inbar O, Lee CC, Mousavi SH, Kano H, Mathieu D, Meola A, Nakaji P, Honea N, Johnson M, Abbassy M, Mohammadi AM, Silva D, Yang HC, Grills I, Kondziolka D, Barnett GH, Lunsford LD, Sheehan J (2017) Stereotactic radiosurgery for intracranial hemangiopericytomas: a multicenter study. J Neurosurg 126:744–754. https://doi.org/10.3171/2016.1.Jns152860

    Article  PubMed  Google Scholar 

  26. Copeland WR, Link MJ, Stafford SL, Pollock BE (2014) Single-fraction stereotactic radiosurgery of meningeal hemangiopericytomas. J Neurooncol 120:95–102. https://doi.org/10.1007/s11060-014-1521-3

    Article  PubMed  Google Scholar 

  27. Ecker RD, Marsh WR, Pollock BE, Kurtkaya-Yapicier O, McClelland R, Scheithauer BW, Buckner JC (2003) Hemangiopericytoma in the central nervous system: treatment, pathological features, and long-term follow up in 38 patients. J Neurosurg 98:1182–1187. https://doi.org/10.3171/jns.2003.98.6.1182

    Article  PubMed  Google Scholar 

  28. Huang L, Bai J, Zhang Y, Cui Z, Zhang Z, Li J, Wang J, Yu X, Ling Z, Qu B, Pan L (2021) Treatment of residual, recurrent, or metastatic intracranial Hemangiopericytomas with Stereotactic Radiotherapy using CyberKnife. Front Oncol 11:577054. https://doi.org/10.3389/fonc.2021.577054

    Article  PubMed  PubMed Central  Google Scholar 

  29. Iwai Y, Yamanaka K (2009) Gamma knife radiosurgery for other primary intra-axial tumors. Prog Neurol Surg 22:129–141. https://doi.org/10.1159/000163395

    Article  PubMed  Google Scholar 

  30. Kano H, Niranjan A, Kondziolka D, Flickinger JC, Lunsford LD (2008) Adjuvant stereotactic radiosurgery after resection of intracranial hemangiopericytomas. Int J Radiat Oncol Biol Phys 72:1333–1339. https://doi.org/10.1016/j.ijrobp.2008.03.024

    Article  PubMed  Google Scholar 

  31. Kim JW, Kim DG, Chung HT, Paek SH, Kim YH, Han JH, Park CK, Kim CY, Jung HW (2010) Gamma Knife stereotactic radiosurgery for intracranial hemangiopericytomas. J Neurooncol 99:115–122. https://doi.org/10.1007/s11060-010-0114-z

    Article  PubMed  Google Scholar 

  32. Kim BS, Kong DS, Seol HJ, Nam DH, Lee JI (2017) Gamma knife radiosurgery for residual or recurrent intracranial hemangiopericytomas. J Clin Neurosci 35:35–41. https://doi.org/10.1016/j.jocn.2016.10.002

    Article  PubMed  Google Scholar 

  33. Olson C, Yen CP, Schlesinger D, Sheehan J (2010) Radiosurgery for intracranial hemangiopericytomas: outcomes after initial and repeat Gamma Knife Surgery. J Neurosurg 112:133–139. https://doi.org/10.3171/2009.3.Jns0923

    Article  PubMed  Google Scholar 

  34. Sheehan J, Kondziolka D, Flickinger J, Lunsford LD (2002) Radiosurgery for treatment of recurrent intracranial hemangiopericytomas. Neurosurgery 51:905–910 discussion 910 – 901. https://doi.org/10.1097/00006123-200210000-00008

    Article  PubMed  Google Scholar 

  35. Sun S, Liu A, Wang C (2009) Gamma knife radiosurgery for recurrent and residual meningeal hemangiopericytomas. Stereotact Funct Neurosurg 87:114–119. https://doi.org/10.1159/000202978

    Article  PubMed  Google Scholar 

  36. Tsugawa T, Mori Y, Kobayashi T, Hashizume C, Shibamoto Y, Wakabayashi T (2014) Gamma knife stereotactic radiosurgery for intracranial hemangiopericytoma. J Radiosurg SBRT 3:29–35

    PubMed  PubMed Central  Google Scholar 

  37. Veeravagu A, Jiang B, Patil CG, Lee M, Soltys SG, Gibbs IC, Chang SD (2011) CyberKnife stereotactic radiosurgery for recurrent, metastatic, and residual hemangiopericytomas. J Hematol Oncol 4:26. https://doi.org/10.1186/1756-8722-4-26

    Article  PubMed  PubMed Central  Google Scholar 

  38. Xiao J, Xu L, Ding Y, Wang W, Chen F, Zhou Y, Zhang F, Zhou Q, Wu X, Li J, Liang L, Jen YM (2021) Does post-operative radiotherapy improve the treatment outcomes of intracranial hemangiopericytoma? A retrospective study. BMC Cancer 21:915. https://doi.org/10.1186/s12885-021-08594-x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Sung KS, Moon JH, Kim EH, Kang SG, Kim SH, Suh CO, Kim SH, Lee KS, Chang WS, Chang JH (2018) Solitary fibrous tumor/hemangiopericytoma: treatment results based on the 2016 WHO classification. J Neurosurg 1–8. https://doi.org/10.3171/2017.9.Jns171057

  40. Kim J (2017) The impact of postoperative radiation therapy on patterns of failure and survival improvement in patients with intracranial hemangiopericytoma. Neurooncology 19:iii117. https://doi.org/10.1093/neuonc/nox036

    Article  Google Scholar 

  41. Stout AP, Murray MR (1942) HEMANGIOPERICYTOMA: A VASCULAR TUMOR FEATURING ZIMMERMANN’S PERICYTES. Ann Surg 116:26–33. https://doi.org/10.1097/00000658-194207000-00004

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 131:803–820. https://doi.org/10.1007/s00401-016-1545-1

    Article  PubMed  Google Scholar 

  43. Schweizer L, Koelsche C, Sahm F, Piro RM, Capper D, Reuss DE, Pusch S, Habel A, Meyer J, Göck T, Jones DT, Mawrin C, Schittenhelm J, Becker A, Heim S, Simon M, Herold-Mende C, Mechtersheimer G, Paulus W, König R, Wiestler OD, Pfister SM, von Deimling A (2013) Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 protein. Acta Neuropathol 125:651–658. https://doi.org/10.1007/s00401-013-1117-6

    Article  CAS  PubMed  Google Scholar 

  44. Jo VY, Fletcher CD (2014) WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition. Pathology 46:95–104. https://doi.org/10.1097/pat.0000000000000050

    Article  CAS  PubMed  Google Scholar 

  45. Trifiletti DM, Mehta GU, Grover S, Sheehan JP (2017) Clinical management and survival of patients with central nervous system hemangiopericytoma in the National Cancer Database. J Clin Neurosci 44:169–174. https://doi.org/10.1016/j.jocn.2017.06.036

    Article  PubMed  Google Scholar 

  46. Tobias S, Jahshan S, Grober Y, Soustiel JF (2022) Skull base hemangiopericytomas. Acta Neurol Belg 122:1537–1545. https://doi.org/10.1007/s13760-021-01812-0

    Article  PubMed  Google Scholar 

  47. Ramakrishna R, Rostomily R, Sekhar L, Rockhill J, Ferreira M (2014) Hemangiopericytoma: radical resection remains the cornerstone of therapy. J Clin Neurosci 21:612–615. https://doi.org/10.1016/j.jocn.2013.08.006

    Article  PubMed  Google Scholar 

  48. Kim BS, Kim Y, Kong DS, Nam DH, Lee JI, Suh YL, Seol HJ (2018) Clinical outcomes of intracranial solitary fibrous Tumor and hemangiopericytoma: analysis according to the 2016 WHO classification of central nervous system tumors. J Neurosurg 129:1384–1396. https://doi.org/10.3171/2017.7.Jns171226

    Article  PubMed  Google Scholar 

  49. Jha N, McNeese M, Barkley HT Jr., Kong J (1987) Does radiotherapy have a role in hemangiopericytoma management? Report of 14 new cases and a review of the literature. Int J Radiat Oncol Biol Phys 13:1399–1402. https://doi.org/10.1016/0360-3016(87)90236-7

    Article  CAS  PubMed  Google Scholar 

  50. Staples JJ, Robinson RA, Wen BC, Hussey DH (1990) Hemangiopericytoma–the role of radiotherapy. Int J Radiat Oncol Biol Phys 19:445–451. https://doi.org/10.1016/0360-3016(90)90556-y

    Article  CAS  PubMed  Google Scholar 

  51. Kwon SM, Na MK, Choi KS, Lim TH, Shin H, Lee J, Lee H, Kim W, Cho Y, Kim JG, Ahn C, Jang BH (2023) Impact of extent of resection and postoperative radiotherapy on survival outcomes in intracranial solitary fibrous tumors: a systematic review and meta-analysis. Neurosurg Rev 46:138. https://doi.org/10.1007/s10143-023-02046-9

    Article  PubMed  Google Scholar 

  52. Konar S, Jayan M, Shukla D, Bhat DI, Nishant S, Nandeesh BN, Devi BI (2021) The risks factor of recurrence after skull base hemangiopericytoma management: a retrospective case series and review of literature. Clin Neurol Neurosurg 208:106866. https://doi.org/10.1016/j.clineuro.2021.106866

    Article  PubMed  Google Scholar 

  53. Spina A, Boari N, Gagliardi F, Donofrio CA, Franzin A, Mortini P (2016) The current role of Gamma Knife radiosurgery in the management of intracranial haemangiopericytoma. Acta Neurochir (Wien) 158:635–642. https://doi.org/10.1007/s00701-016-2742-3

    Article  PubMed  Google Scholar 

  54. Lee A, Sidiqi B, Wang A, Safdieh J, Schreiber D (2018) Patterns of care and outcomes of postoperative radiation for intracranial hemangiopericytoma in United States hospitals. Clin Neurol Neurosurg 167:1–5. https://doi.org/10.1016/j.clineuro.2018.02.004

    Article  PubMed  Google Scholar 

  55. Guthrie BL, Ebersold MJ, Scheithauer BW, Shaw EG (1989) Meningeal hemangiopericytoma: histopathological features, treatment, and long-term follow-up of 44 cases. Neurosurgery 25:514–522

    Article  CAS  PubMed  Google Scholar 

  56. Nair R, Panettieri V, Chang JH, Dally M (2018) Post-operative stereotactic radiotherapy for the treatment of intracranial haemangiopericytoma: ‘A study of dose and outcome’. J Med Imaging Radiat Oncol 62:573–577. https://doi.org/10.1111/1754-9485.12745

    Article  Google Scholar 

  57. Li Q, Deng W, Sun P (2022) Effect of different treatments for Intracranial Solitary Fibrous tumors: retrospective analysis of 31 patients. World Neurosurg 166:e60–e69. https://doi.org/10.1016/j.wneu.2022.06.089

    Article  PubMed  Google Scholar 

  58. Allen AJ, Labella DA, Richardson KM, Sheehan JP, Kersh CR (2022) Recurrent Solitary Fibrous Tumor (Intracranial Hemangiopericytoma) treated with a Novel Combined-Modality Radiosurgery technique: a Case Report and Review of the literature. Front Oncol 12:907324. https://doi.org/10.3389/fonc.2022.907324

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.

Author information

Authors and Affiliations

Authors

Contributions

Manuscript drafting (DG, JDB, HD, TW, PU); Figure and table design (DG, TW, PU, TGW, BC, MS, ARD); Manuscript editing and revision (DG, JDB, HD, TW, ETQ, BC, YZ, AG, SS, MS, ARD); Literature review (DG, JDB, HD, TW, TGW, ETQ, BC); Data Analysis (DG, JDB, HD, PU, TGW, ETQ, BC); Research team management and oversight (DG, ETQ, YZ, AG, SS, MS, ARD).

Corresponding author

Correspondence to Danielle Golub.

Ethics declarations

Competing interests

The authors declare that this research was conducted in the absence of any commercial, financial, or other non-financial relationships that could be construed as a competing interest or a conflict of interest.

Ethics approval

No ethical approval was required for this systematic review of existing published literature.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Golub, D., McBriar, J.D., Donaldson, H. et al. Postoperative stereotactic radiosurgery for intracranial solitary fibrous tumors: systematic review and pooled quantitative analysis. J Neurooncol 165, 229–239 (2023). https://doi.org/10.1007/s11060-023-04499-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-023-04499-w

Keywords

Navigation